Cargando…
NOV/CCN3 attenuates inflammatory pain through regulation of matrix metalloproteinases-2 and -9
BACKGROUND: Sustained neuroinflammation strongly contributes to the pathogenesis of pain. The clinical challenge of chronic pain relief led to the identification of molecules such as cytokines, chemokines and more recently matrix metalloproteinases (MMPs) as putative therapeutic targets. Evidence po...
Autores principales: | Kular, Lara, Rivat, Cyril, Lelongt, Brigitte, Calmel, Claire, Laurent, Maryvonne, Pohl, Michel, Kitabgi, Patrick, Melik-Parsadaniantz, Stéphane, Martinerie, Cécile |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3332238/ https://www.ncbi.nlm.nih.gov/pubmed/22353423 http://dx.doi.org/10.1186/1742-2094-9-36 |
Ejemplares similares
-
Plasma NOV/CCN3 Levels Are Closely Associated with Obesity in Patients with Metabolic Disorders
por: Pakradouni, Jihane, et al.
Publicado: (2013) -
Reduced NOV/CCN3 Expression Limits Inflammation and Interstitial Renal Fibrosis after Obstructive Nephropathy in Mice
por: Marchal, Pierre-Olivier, et al.
Publicado: (2015) -
NOV story: the way to CCN3
por: Perbal, Bernard
Publicado: (2006) -
Matrix Metalloproteinases MMP2 and MMP9 Are Produced in Early Stages of Kidney Morphogenesis but Only MMP9 Is Required for Renal Organogenesis In Vitro
por: Lelongt, Brigitte, et al.
Publicado: (1997) -
Matrix Metalloproteinase 9 Protects Mice from Anti–Glomerular Basement Membrane Nephritis through Its Fibrinolytic Activity
por: Lelongt, Brigitte, et al.
Publicado: (2001)